Frequently Asked Questions

RTI International, the Pennsylvania Department of Health (PA DOH), Temple University, and Brown University received federal funding to study PFAS and possible health effects from drinking PFAS-contaminated water in Pennsylvania.

The goal of the multi-site health study is to learn more about the relationship between PFAS exposure and health outcomes among differing populations exposed to PFAS-contaminated drinking water. It will also compare different levels of PFAS exposure from different sites and health outcomes.

PFAS are human-made chemicals used since the 1950s in a variety of products, including some cosmetics; water, grease, and oil-resistant products; and some fire fighting foams.

There is much to learn, but some studies show high levels of certain PFAS may lead to the following:

  • Increased cholesterol levels
  • Changes in liver enzymes
  • Decreased vaccine response in children
  • Increased risk of high blood pressure or preeclampsia in pregnant women
  • Small decreases in infant birth weights
  • Increased risk of kidney or testicular cancer

Adults who are age 18 and older and children ages 4 through 17 (with parent or guardian permission) who resided in households exposed to PFAS-contaminated drinking water, either via the public water system or private wells, may be eligible. Children exposed in utero or during breastfeeding may also be eligible.

Residents who were potentially exposed to PFAS on their job (e.g., ever worked as a firefighter or used firefighting foam and/or ever worked at facilities using PFAS chemicals) are not eligible to participate.

Residents who only had exposure to PFAS-contaminated drinking water before 2005. Someone would be ineligible to participant in the study if they did not have relatively recent exposure to PFAS contaminated drinking water. This requirement is to ensure that PFAS levels remain high enough to be measured in the blood.

There are no costs for the tests. Adults can receive up to $50 in gift cards for completing the entire study and children can receive up to $75 in gift cards for completing the entire study.

The enrollment goal is 1,000 adults and 300 children. Recruitment will target three groups of participants: volunteers from Horsham, Warminster, and Warrington Township areas (the specific study boundaries will be announced in Fall/Winter of 2020/2021); households who experienced greater concentrations or longer exposures to PFAS (e.g., those in areas closest to the military bases); and the participants who took part in the 2018-2019 Pennsylvania PFAS biomonitoring pilot. More information about the biomonitoring project can be found under Other Studies.

Over the next few months, the study team will meet with community members to answer questions about study planning. In the late spring/summer of 2021, eligible residents will be invited to schedule a clinical visit and complete tests for the study.

Trained professionals from the community will:

  • Collect your blood and urine samples (samples will NOT reveal drug/alcohol use)
  • Take your body and clinical measurements
  • Ask questions about your residential, drinking water usage, occupational, and medical histories
  • Study behaviors in child participants

With your consent, staff will also collect information from your medical records and your child's school records.

The study will examine associations between PFAS compounds and lipids, renal function and kidney disease, thyroid hormones and disease, liver function and disease, glycemic parameters and diabetes, and immune response and function in both children and adults. In addition, the study will investigate PFAS differences in sex hormones and sexual maturation, vaccine response, and neurobehavioral outcomes in children. In adults, additional outcomes of interest include cardiovascular disease, osteoarthritis and osteoporosis, endometriosis, and autoimmune disease.

Participants' results will be used to inform public health specialists on how PFAS impacts human health. In addition, each individual participant will receive their own testing results, enabling them to learn more about their own health.

Aqueous Film Forming Foams (AFFF). Large scale drinking water contamination has occurred in many states among communities near military bases where PFAS were used in firefighting exercises. These bases were routinely performing fire-fighting trainings using PFAS-containing Aqueous Film-Forming Foams (AFFF) for several decades. The use of AFFF in training exercises led to direct emissions of PFAS into surface and ground waters. Montgomery and Bucks counties in Southwestern Pennsylvania were the locations of two such large military bases.

Bucks County. The former Naval Air Warfare Center (NAWC) in Warminster Township, Bucks County, Pennsylvania, was used to research, develop, and test naval aircraft systems, and was located near four of the 18 Warminster Municipal Authority (WMA) public water supply wells. PFAS compounds were detected in the WMA system in the summer of 2013. Further study was performed by the U.S. Environmental Protection Agency (EPA), and as of September 2015, PFAS were detected in 93 out of the 100 private wells within a 1 to 3-mile radius of the military site.

Montgomery County. The Horsham Air Guard Station (HAGS) in Horsham Township, Montgomery County, Pennsylvania located a few miles away from NAWC is on a 1,200-acre site that was shared with the Naval Air Station Joint Reserve Base (NASJRB). Military operations began during the 1920s and the base is currently operated under the Pennsylvania Air National Guard. The AFFF used on the HAGS base resulted in PFAS contamination of two nearby public water systems — the Horsham Water and Sewer Authority (HWSA) and the Warrington Township Water and Sewer Department (WTWSD).

Yes, PFAS drinking water contamination in the area impacted by the former and current DOD bases has been addressed. Contaminated public water wells in the Horsham, Warrington, and Warminster public systems were taken out of service by July 2014 and bottled water and later public water hookups were provided to certain residents with contaminated private wells. A subset of additional private wells with lower levels of PFAS within 25 percent of the PFOS or PFOA PHALs are being monitored through quarterly resampling.

PFOS: Perfluorooctanesulfonic acid
PFOA: Perfluorooctanoic acid
PHALs: Preliminary Health Assessment Levels

about

More Information About the Study

 

Hero

Meet Our Investigators

 

RTI and PA DOH have assembled a collaborative group of experts who have led projects and tasks of similar size and complexity, with expertise in all substantive and technical requirements of the PA PFAS Multi-site Health Study. The study team will be led by Linda Morris Brown, MPH, DrPH (RTI), and Sharon M. Watkins, PhD (PA DOH). Drs. Brown and Watkins will be supported by Co-Investigators from Temple University (Drs. Resa M. Jones and Robin Taylor Wilson) and Brown University (Dr. David Savitz).

Linda Morris Brown, MPH, DrPH

Linda Morris Brown, MPH, DrPH

RTI International
Sharon M. Watkins, PhD

Sharon M. Watkins, PhD

Pennsylvania Department of Health
Resa M. Jones, MPH, PhD

Resa M. Jones, MPH, PhD

Temple University
Robin Taylor Wilson, PhD

Robin Taylor Wilson, PhD

Temple University
David Savitz, PhD

David Savitz, PhD

Brown University

Community Engagement

 

Community Assistance Panel

Susan Wood
Susan Wood

Interested in learning more about the study and helping investigators with recruitment and communication?

Please contact Susan Wood at
PA Department of Health at c-swood@pa.gov.

 

 

Community Meetings

The first PA PFAS Community Meeting was held virtually on July 9, 2020 at 7:00pm EST.

Click here to access the recording of the meeting.

 

 

Community Groups

Stanton
Joanne Stanton
Grosse
Hope Grosse

Buxmont Coalition for Safer Water:
https://www.buxmontwater.org

Other Studies

PFAS Biomonitoring
The PA DOH in 2018 measured PFAS levels in a random sample of 235 residents in the Horsham, Warrington, and Warminster communities. This was a pilot study to determine whether this region has higher than average levels of PFAS compounds in residents’ blood. The community’s average PFAS levels were compared to the U.S. general population and were found overall to be above average. In 2019, PA DOH collected dust and tap water from a random sample of households, and urine samples were collected from the original biomonitoring participants. More information on the national EA work can be found in the next column.
PFAS Exposure Assessment

The CDC and ATSDR are assessing the PFAS exposure in communities near current or former military installations. The exposure assessment compares PFAS levels in blood and urine from the Horsham, Warminster, and Warrington community to levels in the general population or to those reported in other studies. The CDC and ATSDR will also identify and assess environmental factors that affect exposure, like household dust and drinking water.

PA Cancer Studies
PA DOH has performed cancer data reviews over the last 40 years, examining the rates of cancers in the Horsham, Warminster, and Warrington area.
Cancer data review
(1985-2013) - selected zip codes

Evaluated incidence rates of seven cancers (multiple myeloma, non-Hodgkin lymphoma, and cancers of the bladder, kidney, liver, prostate, and testis).

Cancer data review - Addendum 1
(1985-2013) - selected zip codes

Evaluated incidence rates of two additional cancers - pancreatic and pediatric cancers.

Cancer data review - Addendum 2
(1985-2013) - selected zip codes

Improved precision in cancer incidence rate analysis for the above nine cancers by geocoding cancer cases to confirm their geographic location and by using the water service areas as the study area.

Contact

Submit a message below to papfashealth@rti.org or call 1-866-354-1076 for general study information.